title: Balancing innovation, access, and profits--market exclusivity for biologics.
authors.affiliation: Engelberg Foundation, Palm Beach, FL, USA.
authors.forename: Alfred B
authors.initials: AB
authors.lastname: Engelberg
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
authors.forename: Jerry
authors.initials: J
authors.lastname: Avorn
mesh_terms: D001688:Biological Products / Q000191:economics; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D016568:Drugs, Generic; D007880:Legislation, Drug; D040541:Marketing / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011306:Prescription Fees; D014481:United States
chemical_list: D001688:Biological Products; D016568:Drugs, Generic